{"id":463881,"date":"2024-10-20T10:31:17","date_gmt":"2024-10-20T10:31:17","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/aami-cr513-2024\/"},"modified":"2024-10-26T19:23:56","modified_gmt":"2024-10-26T19:23:56","slug":"aami-cr513-2024","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/aami\/aami-cr513-2024\/","title":{"rendered":"AAMI CR513 2024"},"content":{"rendered":"
This consensus report provides guidance on simplified approaches for validation and routine control of single-use systems used for pharmaceutical and biopharmaceutical manufacturing sterilized by radiation.<\/p>\n
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
1<\/td>\n | AAMI CR513:2024; Guidance on radiation sterilization validation and routine control of single-use systems used for pharmaceutical and biopharmaceutical manufacturing <\/td>\n<\/tr>\n | ||||||
3<\/td>\n | Title page <\/td>\n<\/tr>\n | ||||||
4<\/td>\n | AAMI Consensus Report <\/td>\n<\/tr>\n | ||||||
5<\/td>\n | Copyright information Contents <\/td>\n<\/tr>\n | ||||||
6<\/td>\n | Task Group representation <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | 1 Purpose 1.1 Scope 2 References and resources <\/td>\n<\/tr>\n | ||||||
10<\/td>\n | 3 Terms and definitions 4 Definition and maintenance of product families for dose establishment and dose auditing 4.1 Representative product 4.1.1 Master product <\/td>\n<\/tr>\n | ||||||
11<\/td>\n | 4.1.2 Equivalent product 4.1.3 Simulated product 5 Selection and testing of product for establishing the sterilization dose 5.1 Selection of product to be tested 5.2 Sample item portion (SIP) <\/td>\n<\/tr>\n | ||||||
12<\/td>\n | 6 Sterile claim 7 Transfer of dose between radiation types 8 Application of dose 8.1 Application of verification dose to SUSs 8.2 Application of sterilization dose to SUSs <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | 9 Risk assessment 9.1 Risk assessment for SAL 9.2 Risk assessment for simplification of SUSs for testing 10 Guidance on release and independent verification for the user 10.1 SUS release information <\/td>\n<\/tr>\n | ||||||
14<\/td>\n | 10.2 SUS user information 11 Regulatory aspects <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" AAMI CR513:2024 Guidance on radiation validation and routine maintenance for single-use systems used for pharmaceutical and biopharmaceutical manufacturing<\/b><\/p>\n |